Resource Page

ANTIBODY RESPONSE TO PNEUMOCOCCAL CONJUGATE VACCINE 10 AMONG UNDER FIVE CHILDREN, SEEN AT FEDERAL MEDICAL CENTRE, OWERRI

Email:
Supervisor: Professor Emmanuel Ekanem, and Dr. IregbuFrancis
Faculty: PAEDIATRICS
Institution of Training: Federal Medical Centre, Owerri
Month: 05
Year: 2021

Abstract

Streptococcus pneumoniae is a pathogen that is a major cause of morbidity and mortality in children under five years of age. It is responsible for invasive pneumococcal diseases such as pneumonia bacteraemia and meningitis. Pneumococcal conjugate vaccines have been developed to reduce the burden of invasive pneumococcal diseases. A study to determine antibody response to the vaccine is required as a means of assessing the efficacy of the vaccine.

© 2024 NPMCN, All Rights Reserved
Powered by: